Built to transform aerospace power, FAERO™ is designed for long-range, high-speed missions with up to 80% higher energy density and 4X the energy at full power compared with today’s high-power lithium ...
Recursion announces FDA alignment for REC-4881’s Phase 3 trial in familial adenomatous polyposis, targeting crucial adenoma excision outcomes.
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies. Its potential as a first-in-class oral therapy ...
Malicious JavaScript loading through a third-party script layer on November 16, exposing visitors to potential cryptocurrency ...
Claude calling Anthropic's S-1 insightful is zero surprise. Like it was ever going to call its own maker's filing boring.